CHARLEY BECK: Open Payments
NPI 1871255315 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 49 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,427
Food & beverage: $1,201Education: $226
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $261 |
| Regeneron Healthcare Solutions, Inc. | 4 | $258 |
| GENZYME CORPORATION | 5 | $220 |
| Incyte Corporation | 6 | $212 |
| ABBVIE INC. | 7 | $189 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| LEO Pharma Inc. | 2 | $47 |
| PFIZER INC. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Organon LLC | 2 | $25 |
Products named: DUPIXENT, TREMFYA, OPZELURA, SKYRIZI, Rhapsido, ANZUPGO, Winlevi, LITFULO.
Industry payments across CA — which companies pay providers there.
